Semax

Semax is a synthetic brain-boosting peptide developed in Russia, derived from a fragment of ACTH (a hormone that regulates stress response). It's one of the most well-researched nootropics, approved in Russia for stroke recovery and cognitive disorders. **What makes it special?** Semax increases BDNF (brain-derived neurotrophic factor) — essentially "fertilizer" for your brain that promotes the growth of new neurons and strengthens existing connections. **What the research shows:** • Enhances memory, focus, and learning capacity • Provides neuroprotection against oxidative stress and ischemia • May help with stroke recovery and optic nerve diseases • Shows antidepressant-like effects in studies • Supports nerve regeneration **How it works:** Semax modulates dopamine and serotonin systems while boosting BDNF. Unlike stimulants, it enhances cognition without causing jitters or crashes. **Typical use:** Administered as a nasal spray (usually 0.1% solution) for rapid absorption into the brain. Effects typically felt within 15-20 minutes. **N-Acetyl Semax:** An enhanced version with better blood-brain barrier penetration and potentially stronger effects. **Important to know:** Approved in Russia but not FDA-approved in the US. Research is promising but mostly from Russian institutions. --- **Sources:** Ashmarin IP, et al. (1997) Neuroscience and Behavioral Physiology | Dolotov OV, et al. (2006) Neuroscience

Most clinical evidence is published in Russian journals with limited English abstracts, which hampers independent verification. There are no FDA-reviewed trials, long-term safety data in Western populations are unestablished, and use for cognitive enhancement in healthy people is off-label.

Administered intranasally (the registered Russian route); a short half-life requiring repeated dosing. Mechanism proposed via melanocortin receptor modulation with upregulation of BDNF/NGF and neuroprotective signaling.